Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,948,819
Closed -$59.2M 20
2019
Q4
$59.2M Buy
1,948,819
+605,684
+45% +$17.9M 0.78% 17
2019
Q3
$40.5M Buy
1,343,135
+223,314
+20% +$6.59M 0.57% 20
2019
Q2
$33.3M Sell
1,119,821
-6,347,557
-85% -$168M 0.5% 22
2019
Q1
$188M Hold
7,467,378
3.41% 13
2018
Q4
$175M Buy
7,467,378
+1,222,927
+20% +$30.4M 3.67% 13
2018
Q3
$182M Sell
6,244,451
-3,755,549
-38% -$113M 2.78% 15
2018
Q2
$303M Buy
10,000,000
+7,233,000
+261% +$227M 4.1% 12
2018
Q1
$83.5M Buy
+2,767,000
New +$86.5M 0.48% 27
2017
Q1
Sell
-4,168,458
Closed -$113M 44
2016
Q4
$113M Buy
4,168,458
+3,366,890
+420% +$88.6M 0.69% 39
2016
Q3
$22.7M Buy
+801,568
New +$22.4M 0.14% 51

Other funds holding AXTA

Eric Mandelblatt's AXTA Position: Q1 2020 in Review

Eric Mandelblatt sold out of Axalta (AXTA) in Q1 2020, closing a stake of 1,948,819 shares — an estimated $59.2M sold.

Eric Mandelblatt first reported a position in AXTA in Q3 2016 and held it in 10 quarters. The position peaked at $303M in Q2 2018. 331 funds tracked by Wall St. Rank hold AXTA as of Q1 2020.

  • Eric Mandelblatt reported no remaining Axalta position as of Q1 2020 after selling out during the quarter.
  • Eric Mandelblatt sold 1,948,819 Axalta shares in Q1 2020, an estimated $59.2M.
  • Eric Mandelblatt first reported a position in Axalta in Q3 2016 and held it in 10 quarters.
  • Eric Mandelblatt's Axalta position peaked at $303M in Q2 2018.
  • 331 funds tracked by Wall St. Rank held Axalta as of Q1 2020.

Based on Soroban Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.